The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. FDA
Dr. Peter Hotez weighs in on identifying innovative strategies to tackling vaccine hesitancy and the anti-science movement. This free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS), one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. ABOUT THE SPEAKER
Join faculty members from the Schar School’s Biodefense master’s program in a discussion on the future of global health security considering lessons learned from the COVID-19 pandemic. Policy Exchange: The Future of Global Health Security will take place Wednesday, October 13, 2021 at 5:30 p.m. ET in a virtual format. This event highlights faculty from
